Evidence map›Paper›PMID 30792496›Full record

ReviewNature reviews. Cardiology2019

Postoperative atrial fibrillation: mechanisms, manifestations and management.

Dobromir Dobrev, Martin Aguilar, Jordi Heijman, Jean-Baptiste Guichard, Stanley Nattel

4 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 328 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
328citing papers in PubMed, 15 pooled it
35.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05062239 narecruitingnot on this mapstarted 2022, after this paper: background citation

Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins - Randomized Controlled Trial

TypeinterventionalSponsorLars Peter RiberRan2022 to 2027Enrolled100ConditionsPostoperative Atrial FibrillationArmsDiscontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days postoperative, No-intervention.
NCT05076019 narecruitingnot on this mapstarted 2022, after this paper: background citation

Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement - a Randomized Controlled Trial

TypeinterventionalSponsorOdense University HospitalRan2022 to 2027Enrolled266ConditionsPostoperative Atrial FibrillationArmsAtorvastatin 80mg, Placebo
NCT05448521 unknown statusnot on this mapstarted 2022, after this paper: background citation

Association of Postoperative Lactate Levels With Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Graft Surgery

TypeobservationalSponsorBaşakşehir Çam & Sakura City HospitalRan2022 to 2023Enrolled250ConditionsCoronary Artery Disease, Atrial Fibrillation
NCT07755072 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Effect of Ligament of Marshall Excision During Minimally Invasive Cardiac Surgery-Coronary Artery Bypass Grafting (MICS-CABG) on the Prevention of Postoperative New-Onset Atrial Fibrillation: A Multicenter, Prospective, Randomized, Triple-Blinded Study

TypeinterventionalSponsorPeking University Third HospitalRan2026 to 2028Enrolled628ConditionsPostoperative Atrial FibrillationArmsMICS-CABG combined with excision of the Ligament of Marshall
3 · Its place in the literature

Who cites it

328 citing papers in PubMed, 15 syntheses or guidelines pooled it, 577 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Perioperative Arrhythmias.Deutsches Arzteblatt international · 2023
    Pooled it
  14. Pooled it
  15. Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Pooled it
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

268 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 4 countries.

Dobromir DobrevDepartment of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.
Martin AguilarDepartment of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.
Jordi HeijmanInstitute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.
Jean-Baptiste GuichardDepartment of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.
Stanley NattelDepartment of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada. stanley.nattel@icm-mhi.org.ORCID http://orcid.org/0000-0002-5565-3311
Montreal Heart Institute · CAMaastricht University · NL

Funding

The Role of Inflammasome in the Pathogenesis of Atrial FibrillationR01HL136389 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Na Li · 2017 to 2026
$5.6M
Sex-specific arrhythmogenic mechanisms of atrial fibrillationR01HL131517 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Eleonora Grandi · 2016 to 2026
$5.0M
NHLBI NIH HHS R01 HL131517NHLBI NIH HHS R01 HL136389
6 · The paper itself

Abstract

Postoperative atrial fibrillation (POAF) complicates 20-40% of cardiac surgical procedures and 10-20% of non-cardiac thoracic operations. Typical features include onset at 2-4 days postoperatively, episodes that are often fleeting and a self-limited time course. Associated adverse consequences of POAF include haemodynamic instability, increased risk of stroke, lengthened hospital and intensive care unit stays and greater costs. Underlying mechanisms are incompletely defined but include intraoperative and postoperative phenomena, such as inflammation, sympathetic activation and cardiac ischaemia, that combine to trigger atrial fibrillation, often in the presence of pre-existing factors, making the atria vulnerable to atrial fibrillation induction and maintenance. A better understanding of the underlying mechanisms might enable the identification of new therapeutic targets. POAF can be prevented by targeting autonomic alterations and inflammation. β-Blocker prophylaxis is the best-established preventive therapy and should be started or continued before cardiac surgery, unless contraindicated. When POAF occurs, rate control usually suffices, and routine rhythm control is unnecessary; rhythm control should be reserved for patients who develop haemodynamic instability or show other indications that rate control alone will be insufficient. In this Review, we summarize the epidemiological and clinical features of POAF, the available pathophysiological evidence from clinical and experimental investigations, the results of prophylactic and therapeutic approaches and the consensus recommendations of various national and international societies.

Indexed as

Adrenergic beta-AntagonistsAmiodaroneAnimalsAnti-Arrhythmia AgentsAtrial FibrillationCalcium Channel BlockersCardiac Pacing, ArtificialCardiac Surgical ProceduresHeart AtriaHeart RateHumansMyocardial IschemiaPostoperative ComplicationsPractice Guidelines as TopicSotalolAdrenergic beta-AntagonistsAmiodaroneAnti-Arrhythmia AgentsCalcium Channel BlockersSotalol

Identifiers

PMID30792496
OpenAlexW2917884932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.